143 related articles for article (PubMed ID: 28751379)
1. The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer.
Jansson AM; Csiszar A; Maier J; Nyström AC; Ax E; Johansson P; Schiavone LH
J Biol Chem; 2017 Sep; 292(37):15501-15511. PubMed ID: 28751379
[TBL] [Abstract][Full Text] [Related]
2. Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis.
Kral M; Klimek C; Kutay B; Timelthaler G; Lendl T; Neuditschko B; Gerner C; Sibilia M; Csiszar A
FEBS J; 2017 Oct; 284(20):3484-3505. PubMed ID: 28837266
[TBL] [Abstract][Full Text] [Related]
3. The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness.
Schmidt U; Heller G; Timelthaler G; Heffeter P; Somodi Z; Schweifer N; Sibilia M; Berger W; Csiszar A
J Exp Clin Cancer Res; 2021 Feb; 40(1):69. PubMed ID: 33596971
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-like EMT inducer (ILEI) promotes melanoma invasiveness and is transcriptionally up-regulated by upstream stimulatory factor-1 (USF-1).
Noguchi K; Dincman TA; Dalton AC; Howley BV; McCall BJ; Mohanty BK; Howe PH
J Biol Chem; 2018 Jul; 293(29):11401-11414. PubMed ID: 29871931
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of factors related to FAM3C/ILEI dimerization and identification of inhibitor candidates targeting cancer treatment.
Flores RMA; Pantaleão SQ; Araujo SC; Malpartida HMG; Honorio KM
Comput Biol Chem; 2023 Jun; 104():107869. PubMed ID: 37068312
[TBL] [Abstract][Full Text] [Related]
7. TGFβ promotes breast cancer stem cell self-renewal through an ILEI/LIFR signaling axis.
Woosley AN; Dalton AC; Hussey GS; Howley BV; Mohanty BK; Grelet S; Dincman T; Bloos S; Olsen SK; Howe PH
Oncogene; 2019 May; 38(20):3794-3811. PubMed ID: 30692635
[TBL] [Abstract][Full Text] [Related]
8. ILEI is an important intermediate participating in the formation of TGF-β1-induced renal tubular EMT.
Zhao X; Luo G; Fan Y; Ma X; Zhou J; Jiang H
Cell Biochem Funct; 2018 Mar; 36(2):46-55. PubMed ID: 29336056
[TBL] [Abstract][Full Text] [Related]
9. ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression.
Lahsnig C; Mikula M; Petz M; Zulehner G; Schneller D; van Zijl F; Huber H; Csiszar A; Beug H; Mikulits W
Oncogene; 2009 Feb; 28(5):638-50. PubMed ID: 19015638
[TBL] [Abstract][Full Text] [Related]
10. ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549.
Song Q; Sheng W; Zhang X; Jiao S; Li F
Tumour Biol; 2014 Feb; 35(2):1377-82. PubMed ID: 24072492
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression.
Csiszar A; Kutay B; Wirth S; Schmidt U; Macho-Maschler S; Schreiber M; Alacakaptan M; Vogel GF; Aumayr K; Huber LA; Beug H
Breast Cancer Res; 2014 Sep; 16(5):433. PubMed ID: 25212966
[TBL] [Abstract][Full Text] [Related]
13. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.
Waerner T; Alacakaptan M; Tamir I; Oberauer R; Gal A; Brabletz T; Schreiber M; Jechlinger M; Beug H
Cancer Cell; 2006 Sep; 10(3):227-39. PubMed ID: 16959614
[TBL] [Abstract][Full Text] [Related]
14. FAM3B PANDER and FAM3C ILEI represent a distinct class of signaling molecules with a non-cytokine-like fold.
Johansson P; Bernström J; Gorman T; Oster L; Bäckström S; Schweikart F; Xu B; Xue Y; Schiavone LH
Structure; 2013 Feb; 21(2):306-13. PubMed ID: 23333428
[TBL] [Abstract][Full Text] [Related]
15. Parallel homodimer structures of the extracellular domains of the voltage-gated sodium channel β4 subunit explain its role in cell-cell adhesion.
Shimizu H; Tosaki A; Ohsawa N; Ishizuka-Katsura Y; Shoji S; Miyazaki H; Oyama F; Terada T; Shirouzu M; Sekine SI; Nukina N; Yokoyama S
J Biol Chem; 2017 Aug; 292(32):13428-13440. PubMed ID: 28655765
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Release of ILEI/FAM3C and Amyloid-β Is Associated with the Activation of Distinct Synapse Subpopulations.
Nakano M; Mitsuishi Y; Liu L; Watanabe N; Hibino E; Hata S; Saito T; Saido TC; Murayama S; Kasuga K; Ikeuchi T; Suzuki T; Nishimura M
J Alzheimers Dis; 2021; 80(1):159-174. PubMed ID: 33492290
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI.
Chaudhury A; Hussey GS; Ray PS; Jin G; Fox PL; Howe PH
Nat Cell Biol; 2010 Mar; 12(3):286-93. PubMed ID: 20154680
[TBL] [Abstract][Full Text] [Related]
18. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
[TBL] [Abstract][Full Text] [Related]
19. The FAM3 superfamily member ILEI ameliorates Alzheimer's disease-like pathology by destabilizing the penultimate amyloid-β precursor.
Hasegawa H; Liu L; Tooyama I; Murayama S; Nishimura M
Nat Commun; 2014 Jun; 5():3917. PubMed ID: 24894631
[TBL] [Abstract][Full Text] [Related]
20. Neuronal expression of ILEI/FAM3C and its reduction in Alzheimer's disease.
Liu L; Watanabe N; Akatsu H; Nishimura M
Neuroscience; 2016 Aug; 330():236-46. PubMed ID: 27256505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
